000000357 001__ 357
000000357 005__ 20231128134409.0
000000357 0247_ $$2DOI$$a10.6083/M4QV3JHF
000000357 037__ $$aETD
000000357 245__ $$aAugmenting the effector phase of adoptive T cell immunotherapy of cancer
000000357 269__ $$a2009
000000357 336__ $$aDissertation
000000357 502__ $$bPh.D.
000000357 540__ $$fCC BY
000000357 542__ $$fIn copyright - single owner
000000357 650__ $$aImmune System$$020666
000000357 650__ $$aImmunotherapy$$020724
000000357 650__ $$aNeoplasms$$022758
000000357 6531_ $$aadoptive
000000357 691__ $$aSchool of Medicine$$041369
000000357 692__ $$aDepartment of Molecular and Medical Genetics$$041428
000000357 7001_ $$aFriedman, Kevin M.
000000357 8564_ $$9fcc61c66-0cc3-4fff-87e6-656835ba8435$$s1247138$$uhttps://digitalcollections.ohsu.edu/record/357/files/358_etd.pdf
000000357 905__ $$a/rest/prod/5d/86/p0/22/5d86p0224
000000357 909CO $$ooai:digitalcollections.ohsu.edu:357$$pstudent-work
000000357 980__ $$aTheses and Dissertations